My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 49

    1.

    A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer.

    Huidobro C, Urdinguio RG, Rodríguez RM, Mangas C, Calvanese V, Martínez-Camblor P, Ferrero C, Parra-Blanco A, Rodrigo L, Obaya AJ, Suárez-Fernández L, Astudillo A, Hernando H, Ballestar E, Fernández AF, Fraga MF.

    Eur J Cancer. 2012 Jan 13. [Epub ahead of print]

    PMID:
    22244828
    [PubMed - as supplied by publisher]

    Related citations

    2.

    Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer.

    Mekenkamp LJ, Heesterbeek KJ, Koopman M, Tol J, Teerenstra S, Venderbosch S, Punt CJ, Nagtegaal ID.

    Eur J Cancer. 2012 Mar;48(4):501-9. Epub 2012 Jan 4.

    PMID:
    22226571
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial.

    Kennecke H, Berry S, Wong R, Zhou C, Tankel K, Easaw J, Rao S, Post J, Hay J.

    Eur J Cancer. 2012 Jan;48(1):37-45. Epub 2011 Jun 12.

    PMID:
    21664123
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.

    Kawamura M, Toiyama Y, Tanaka K, Saigusa S, Okugawa Y, Hiro J, Uchida K, Mohri Y, Inoue Y, Kusunoki M.

    Eur J Cancer. 2011 Dec 23. [Epub ahead of print]

    PMID:
    22197219
    [PubMed - as supplied by publisher]

    Related citations

    5.

    Response prediction in metastasised colorectal cancer using intratumoural thymidylate synthase: Results of a randomised multicentre trial.

    Kornmann M, Hebart H, Danenberg K, Goeb R, Staib L, Kron M, Henne-Bruns D, Danenberg P, Link KH.

    Eur J Cancer. 2011 Nov 29. [Epub ahead of print]

    PMID:
    22133572
    [PubMed - as supplied by publisher]

    Related citations

    6.

    Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer.

    Khattak MA, Townsend AR, Beeke C, Karapetis CS, Luke C, Padbury R, Maddern G, Roder D, Price TJ.

    Eur J Cancer. 2012 Jun;48(9):1293-8. Epub 2011 Nov 24.

    PMID:
    22119202
    [PubMed - in process]

    Related citations

    7.

    The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.

    Hong SP, Min BS, Kim TI, Cheon JH, Kim NK, Kim H, Kim WH.

    Eur J Cancer. 2012 May;48(8):1235-43. Epub 2011 Nov 7.

    PMID:
    22071131
    [PubMed - in process]

    Related citations

    8.

    Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases.

    Ercolani G, Cucchetti A, Cescon M, Peri E, Brandi G, Del Gaudio M, Ravaioli M, Zanello M, Pinna AD.

    Eur J Cancer. 2011 Oct;47(15):2291-8. Epub 2011 Jun 7. Review.

    PMID:
    21652204
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    Re-challenge and the concept of lines of therapy in metastatic colorectal cancer.

    de Gramont A.

    Eur J Cancer. 2011 Sep;47 Suppl 3:S76-84. Review. No abstract available.

    PMID:
    21944033
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Surgery of the primary in stage IV colorectal cancer with unresectable metastases.

    Verhoef C, de Wilt JH, Burger JW, Verheul HM, Koopman M.

    Eur J Cancer. 2011 Sep;47 Suppl 3:S61-6. Review.

    PMID:
    21944031
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Current standards and new trends in the primary treatment of colorectal cancer.

    Stein A, Atanackovic D, Bokemeyer C.

    Eur J Cancer. 2011 Sep;47 Suppl 3:S312-4. Review. No abstract available.

    PMID:
    21943995
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Screening for colorectal cancer: sense and sensibilities.

    Van Hal G, Hoeck S, Van Roosbroeck S.

    Eur J Cancer. 2011 Sep;47 Suppl 3:S156-63.

    PMID:
    21943969
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Chairperson's introduction: Survival of patients with metastatic colorectal cancer has dramatically improved over the last decade. .

    van de Velde CJ.

    Eur J Cancer. 2011 Sep;47 Suppl 3:S50-1. No abstract available.

    PMID:
    21944028
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Management of local recurrence of rectal cancer.

    Wiggers T.

    Eur J Cancer. 2011 Sep;47 Suppl 3:S290-1. No abstract available.

    PMID:
    21943987
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Suppression of retinoid X receptor alpha and aberrant β-catenin expression significantly associates with progression of colorectal carcinoma.

    Zhang F, Meng F, Li H, Dong Y, Yang W, Han A.

    Eur J Cancer. 2011 Sep;47(13):2060-7. Epub 2011 May 9.

    PMID:
    21561764
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Differential gene expression signatures between colorectal cancers with and without KRAS mutations: crosstalk between the KRAS pathway and other signalling pathways.

    Watanabe T, Kobunai T, Yamamoto Y, Matsuda K, Ishihara S, Nozawa K, Iinuma H, Ikeuchi H, Eshima K.

    Eur J Cancer. 2011 Sep;47(13):1946-54. Epub 2011 Apr 29.

    PMID:
    21531130
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Type 2 diabetes mellitus and colorectal cancer: Meta-analysis on sex-specific differences.

    Krämer HU, Schöttker B, Raum E, Brenner H.

    Eur J Cancer. 2012 Jun;48(9):1269-82. Epub 2011 Aug 31.

    PMID:
    21889332
    [PubMed - in process]

    Related citations

    18.

    Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility.

    Xiang HP, Geng XP, Ge WW, Li H.

    Eur J Cancer. 2011 Nov;47(17):2546-51. Epub 2011 Jul 30.

    PMID:
    21807500
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy.

    Simkens LH, Koopman M, Mol L, Veldhuis GJ, Ten Bokkel Huinink D, Muller EW, Derleyn VA, Teerenstra S, Punt CJ.

    Eur J Cancer. 2011 Nov;47(17):2560-7. Epub 2011 Jul 29.

    PMID:
    21803570
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Spatial variation in stage distribution in colorectal cancer in the Netherlands.

    Elferink MA, Pukkala E, Klaase JM, Siesling S.

    Eur J Cancer. 2012 May;48(8):1119-25. Epub 2011 Jul 29.

    PMID:
    21803568
    [PubMed - in process]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk